Could this beaten-down ASX 200 share be packing nearly 20% upside now?

Investors may be reanalysing the outlook for the ASX 200 stock following an earnings update and contract renewal announcement on Wednesday.

S&P/ASX 200 Index (ASX: XJO) share Smartgroup Corporation Ltd (ASX: SIQ) is enjoying a solid lift today.

The company, which provides outsourced administrative and vehicle fleet management services, is up 2.5% in afternoon trade at $4.74 per share.

That will come as welcome news to shareholders who've watched the Smartgroup share price tumble 43% over the past six months.

Also likely to raise the spirits of investors in the ASX 200 share was the latest upgrade by Morgans.

The broker has raised Smartgroup stock to an 'add' classification with a price target of $5.65 per share.

That represents a 19.2% upside to the current share price.

A young male worker climbs a ladder.

Image source: Getty Images

What's been happening with this beaten-down ASX 200 share?

Investors may be reanalysing the outlook for Smartgroup shares following Wednesday's earnings update and contract renewal announcement.

On the contract end, the ASX 200 share reported that one of its major customers, the Health Administration Corporation of New South Wales (NSW Health), renewed its salary packaging and novated leasing services arrangements. Including extensions, the renewed agreement runs until 2028.

As for earnings expectations, Smartgroup estimated its full 2022 calendar year NPATA to be in the range of $60 million to $61 million. (The company notes that NPATA is net profit after tax, "adjusted to exclude the non-cash tax effected amortisation of intangibles and significant non-operating items".)

Commenting on Wednesday's update that could be spurring ASX 200 investor interest, Smartgroup CEO Tim Looi said:

We expect to deliver a full-year profit result that demonstrates the resilience of our business in the face of a difficult economic environment and continuing car supply constraints. We are very pleased to have renewed our contract with NSW Health and look forward to continuing this excellent long-standing relationship.

Smartgroup share price snapshot

The Smartgroup share price has dropped 37% over the past 12 months. For some context, the ASX 200 is down 2% over that same period.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended SMARTGROUP DEF SET. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a remarkably positive end to the trading week.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

One large yellow sphere on one side of a white seesaw, with a small yellow sphere on the other side.
Opinions

I investigated 3 ASX shares that have fallen sharply. Are they bargains or value traps?

I've given my verdict on three depressed high-profile stocks.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Opinions

These are the best 3 ASX growth shares I own and I'd buy more of today

I’m bullish about the earnings potential of these three ASX growth shares.

Read more »